Primary Care Clinics in Hackensack, MN Accepting Medicare
2 Primary Care Clinics found. Showing 1 - 2
 Birch Lake Counseling Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 122 1st St. N., Hackensack, MN 56452 Phone: 218-675-5101 Fax: 801-340-9860 |
Essentia Health St. Joseph's-hackensack Clinic Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 110 3rd St. S, Hackensack, MN 56452 Phone: 218-675-5044 Fax: 218-675-5048 |
News Archive
Minority parents more receptive to vaccinating their daughters against HPV, finds new study
A new Boston University School of Medicine study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus, while white, middle-class parents are more likely to defer the vaccination.
Researchers determine the predictability of Ebola's trajectory in China and throughout Southeast Asia
What exactly happened in Asia that caused SARS-CoV-2 to rapidly spread across the region and then essentially came to a halt there? That's what researchers from the University of South Florida are trying to determine in a new study funded by an NSF Rapid Response grant.
Researchers give mutants another chance
Researchers at Fox Chase Cancer Center have demonstrated that it might be possible to treat genetic diseases, including some forms of cancer, by "rescuing" the misshapen, useless proteins produced by some mutant genes.
Chemical senses scientists to hold 33rd annual meeting, April 13-17, 2011
The Association for Chemoreception Sciences (AChemS), a US-based scientific organization, is holding its 33rd annual meeting. About 700 scientists are gathering to present new information on the role of smell and taste in disease, nutrition, and social interactions in humans as well as animals. Smell and taste play essential roles in our daily lives.
New data on Merck's VICTRELIS for chronic HCV to be presented at EASL annual meeting
Merck, known as MSD outside of the United States and Canada, announced today that two analyses of VICTRELIS (boceprevir) and data from Phase II studies of two of Merck's investigational medicines for chronic hepatitis C virus (HCV) genotype 1, MK-5172 and vaniprevir (MK-7009), will be presented at the 2013 International Liver Congress (EASL) Annual Meeting.
› Verified 6 days ago